QQ客服 官方微博 反馈留言

	A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
	Song, Jiangdian; Shi, Jingyun; Dong, Di; Fang, Mengjie; Zhong, Wenzhao; Wang, Kun; Wu, Ning; Huang, Yanqi; Liu, Zhenyu; Cheng, Yue
	2018
卷号	24期号:15页码:3583-3592
ISSN号	1078-0432
DOI	10.1158/1078-0432.CCR-17-2507
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6360095
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Song, Jiangdian,Shi, Jingyun,Dong, Di,et al. A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy[J],2018,24(15):3583-3592.
APA	Song, Jiangdian.,Shi, Jingyun.,Dong, Di.,Fang, Mengjie.,Zhong, Wenzhao.,...&Tian, Jie.(2018).A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy.,24(15),3583-3592.
MLA	Song, Jiangdian,et al."A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy".24.15(2018):3583-3592.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。